John Rinker II, MD
John Rinker II, MD
John Rinker II, MD
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>John</strong> R. <strong>Rinker</strong> <strong>II</strong>, <strong>MD</strong><br />
University of Alabama at Birmingham<br />
Birmingham VA Medical Center<br />
August 28, 2012
This continuing education activity is managed<br />
and accredited by Professional Education<br />
Service Group. The information presented in<br />
this activity represents the opinion of the<br />
faculty. Neither PESG, nor any accrediting<br />
organization endorses any commercial<br />
products displayed or mentioned in<br />
conjunction with this activity.<br />
Commercial Support was not received for this<br />
activity.
<strong>John</strong> <strong>Rinker</strong>, <strong>MD</strong><br />
• Grants/research support: Biogen Idec: Site PI<br />
for clinical trial; Investigator-initiated study<br />
• Consultant/advisory board member: N/A<br />
• Speaker’s Bureau: N/A<br />
• Honoraria from Industry: N/A<br />
CME Staff Disclosures<br />
• Professional Education Services Group staff have<br />
no financial interest or relationships to disclose
At the conclusion of this activity, the<br />
participant will be able to:<br />
1. Review the military service<br />
experiences of two Gulf War-era<br />
veterans with MS<br />
2. Summarize the possible MS risk<br />
factors experienced by these veterans<br />
3. Discuss the difficulty of linking MS<br />
onset with individual exposure
56 y/o white male, born 1955<br />
1973: Enlisted in the Army at age 18.<br />
Served until 1975. No combat exposure.<br />
1980: Re-enlisted into the Navy, where he<br />
served until medically discharged in<br />
1998
1981-84: Stationed at Camp Lejeune, NC.<br />
Exposed to well water contaminated with<br />
perchloroethylene (PCE) and<br />
trichloroethylene (TCE) 1<br />
1983: On-board helicopter involved in<br />
the invasion of Grenada<br />
1<br />
VA has attributed at least 2 cases of cancer to this exposure
1990-91: Desert<br />
Shield/Desert Storm, Kuwait<br />
and Iraq.<br />
Hospital Corpsman/ Research<br />
Technician.<br />
• Oil-well fires<br />
• Collected soil and air samples<br />
collected to analyze for<br />
contaminants which indicated<br />
chemical & biological weapons
1982 (at Camp Lejeune): Hand<br />
paresthesias for several weeks without<br />
functional impairment. Resolved back to<br />
baseline.<br />
1993, 94: Vertigo/dysequilibrium. MRI<br />
‘abnormal.’<br />
1996: Balance disturbance<br />
1998: Optic neuritis, improved following<br />
IVSM followed by plasma exchange.
Medical: PTSD<br />
Social: Smokes cigarettes<br />
Family: No history of MS or autoimmunity
1998 MRI showed worsening lesion<br />
burden compared to 1994<br />
Lumbar puncture ‘abnormal’<br />
Evoked potentials confirmed optic nerve<br />
conduction delay<br />
Vitamin B12 normal, MS mimics ‘ruled<br />
out’<br />
MS diagnosed May 1998
Sep 1998: Started SQ interferon beta-1b<br />
Using crutches intermittently for gait<br />
instability<br />
Symptoms gradually worsening through<br />
to present<br />
2001: Switched to glatiramer acetate due<br />
to side effects on interferon<br />
2000’s: Neurogenic bladder, worsening<br />
gait, occasional falls<br />
2012: EDSS 6.5
43 y/o African-American female, born<br />
1968<br />
National Guard member, employed by<br />
Alabama Dept. of Corrections<br />
Called to active duty April 2003<br />
Deployed to Afghanistan July 2003 for 8<br />
month tour of duty
Pre-deployment: Vaccinations against<br />
small pox, anthrax; anti-malarial pills<br />
July 2003-March 2004: Assigned to<br />
provide armed support for Explosive<br />
Ordinance Disposal team<br />
2005: Deployed to Gulf of Mexico in<br />
aftermath of Ivan and Katrina
Mid-2004: New onset severe headaches<br />
shortly after end of duty tour<br />
2007: Recurring urinary urgency/<br />
incontinence; diagnosed with<br />
“fibromyalgia,” treated with SSRIs<br />
2011: Ascending numbness from feet to<br />
chest and hands over 3 days; mild to<br />
moderate functional impairment at peak
Medical: PTSD; Migraines<br />
Social: Cigarette use, ½ to 1 ppd; rare<br />
alcohol, no illicit drugs<br />
Family: No history of MS or autoimmunity
Visual acuity normal, no red desaturation<br />
Cranial nerves normal<br />
Motor: R hand 4-/5, L hand 5/5; R psoas<br />
4/5, L psoas 4+/5; other muscle groups<br />
normal<br />
Sensory: Absent sharp-dull<br />
discrimination in feet<br />
Reflexes: RUE>LUE; LLE>RLE<br />
No tremor, ataxia. Gait steady.
CSF:<br />
• WBC – 4, RBC – 0<br />
• Protein 32<br />
• Glucose 61<br />
• IgG index 0.7 (ULN<br />
0.66)<br />
• + OCBs<br />
• CSF ACE normal<br />
Normal lab work:<br />
• ANA<br />
• B12<br />
• CRP<br />
• Lyme Ab<br />
• Anti-SSA & B Ab<br />
• RPR<br />
• HIV<br />
• ACE level
April 2009 April 2011
Started SQ Interferon beta-1a mid-2011<br />
No relapse activity since starting<br />
interferon<br />
Follow-up MRI late 2011:<br />
Stable lesion burden<br />
May 2012: EDSS 1.5
SUBJECT 1 SUBJECT 2<br />
Organic solvents<br />
Oil well fires<br />
Air/soil samples<br />
contaminated by<br />
chemical/ biological<br />
weapons?<br />
Cigarette smoke<br />
PTSD<br />
Pre-deployment<br />
vaccinations<br />
Theater of combat<br />
Cigarette smoke<br />
PTSD<br />
Katrina/Ivan<br />
aftermath
If you would like to receive continuing<br />
education credit for this activity, please<br />
visit:<br />
http://pva.cds.pesgce.com/